CCTV+:Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
10.12.2020 12:30:00 EET | Business Wire | Press release
A statement on strengthening media cooperation issued by China Media Group (CMG) and its European media partners, calling on the Chinese and European media to fulfill their responsibilities as public information disseminators and jointly help the international community to gather a strong force to overcome the pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201210005312/en/
CMG and its European media partners issued the statement. /CCTV+ (Photo: Business Wire)
CMG and its European media partners issued the statement. /CCTV+
The statement was made during the “2020 European Media Partners Cooperation Online Forum” on December 10, hosted by CMG with the theme of “Mutual Trust Dialogue for Win-Win Cooperation”.
Twenty-eight delegates from 25 organizations in 16 European countries and China had in-depth discussions on how to strengthen coordination, deepen ties, unite to fight the pandemic, and bring greater confidence to the world through in-depth exchanges.
CMG’s President and Editor-in-Chief, Shen Haixiong put forward three proposals on the current media situation. He said, “First, we should deepen cooperation in reporting COVID-19 responses; Second, we should promote the exchange of personnel between the media organizations; Third, we should strengthen the construction of our cooperation mechanism.”
In his speech, he pointed out, China and Europe share a broad consensus and common interests in supporting and practicing multilateralism, strengthening the global response to COVID-19, and jointly promoting global economic recovery and addressing the issue of climate change. We share far more consensus than divergences. Chinese and European media partners will also move towards a new stage of closer, deeper, and more pragmatic dialogue, exchange and cooperation.
Michael Friedenberg, the President of Reuters, said, “We must recognize the power of partnerships in this new media ecosystem. This can take the form of collaborative journalism, industry coalitions, new commercial business opportunities, content-sharing or shared platforms.”
He also mentioned CMG and CCTV+ are important partners and our partnership continues to be a priority.
“Without a clear two-way information communication, there will never be full trust and in-depth cooperation. Therefore, in a friendly relation between different countries and peoples, the media plays a vital role,” said Paolo Panerai, the Editor-in-Chief & CEO of Class Editori S.p.A.’s.
“As global interdependence grows, I believe that media companies cannot work in silos anymore,” Michael Peters, CEO and President of Executive Board of Euronews emphasized. He believes that Euronews and CMG will continue to deepen our collaboration in fostering a better understanding between our cultures.
A launch ceremony of China Business Video (CBV) was also held between CCTV+ and Reuters. It provides Reuters’ customers with financial news content from China, which will be distributed straight by CMG to improve media cooperation between China and other media and to strengthen information exchanges.
At the forum, Teng Yunping, President of CCTV Video News Agency (CCTV+), and Adrian Wells, Managing Director of European News Exchange (ENEX) signed a Strategic Memorandum of Understanding, which signals the official launch of the “European Media Partners (EMP)”. In the future, the two sides will strengthen cooperation on news materials, news reports, overseas reporters, news products, and media forums.
At the same time, the program, BizToday, was released to provide “European Media Partners” with tailored Chinese and European financial news jointly created by CMG, CCTV+ and ENEX.
During the forum, representatives from China and Europe joined an online panel discussion with the theme “Multilateral Cooperation and Mutual Trust, Common Challenges and Win-Win Future” to discuss how the Chinese and European media promote mutual trust between people from both sides and carry out multilateral cooperation to achieve win-win results.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201210005312/en/
Contact information
CCTV+(China）
YU Xiao
Email: yuxiao@cctvplus.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom